EP300 and lymphoma: In contrast, CBP, KAT inhibitors discovered recently, and A485, p300 inhibitor, showed antiproliferative effects on lineage-specific tumor cell lines [48]; however, KAT6A and KAT6B inhibitors induced cell senescence and inhibited mouse lymphoma growth [49].